ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Clinical trial NCT00339131 · COMPLETED

Trial details

NCT number: NCT00339131
Sponsor: Molecular Insight Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pheochromocytoma Paraganglioma Carcinoid

Start date: 2006-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.